Ceftizoxime
Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan.
Product Specifications
CAS Number
68401-81-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Ceftizoxime.html
Purity
99.90
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(C(N12)=CCS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O
Molecular Formula
C13H13N5O5S2
Molecular Weight
383.40
Precautions
H302, H315, H319, H335
References & Citations
[1]Kamimura T, et al. Ceftizoxime (Ceftizoxime), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1979 Nov;16 (5) :540-8.|[2]Murakawa T, et al. Pharmacokinetics of ceftizoxime in animals after parenteral dosing. Antimicrob Agents Chemother. 1980 Feb;17 (2) :157-64.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
β-lactam
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
41455151 3x 1.0 µg DNA
RPL34P14 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
123082-HRP 100 µL
AHCYL1 (Putative Adenosylhomocysteinase 2, AdoHcyase 2, DC-expressed AHCY-like Molecule, S-adenosyl-L-homocysteine Hydrolase 2, S-adenosylhomocysteine Hydrolase-like Protein 1, DCAL, XPVKONA) (HRP)
Sign In for Pricing
View Details MBS9336296-01 48 Well
Rat Gamma-aminobutyric acid receptor subunit delta, GABRD ELISA Kit
Sign In for Pricing
View Details